Get your free ETF data sample from our comprehensive offerings. Start your free trial→
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
244580 ETF · Samsung KODEX Biotech ETF
The 244580 Exchange Traded Fund (ETF) is provided by Samsung Asset Management. It is built to track an index: FnGuide Inc Bio Index. The 244580 ETF provides physical exposure, so by buying it you actually own parts of all the 42 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update Today at 12:00 AM UTC
LIVE
CLOSED
This fund is part ofAPAC Blended Cap1M perf.+9.23%
Last price
â‚©12,180
1M perf.
-5.41%
1M flows
+€2.8M
AuM
€168M
E/R
0.45%
Rating
Not rated
ESG Consensus®
244580
â‚©12,180
Performance & flows
Segment for quartile rank
January 20, 2026 → April 20, 2026
Create a free account to view the flows graph
244580
â‚©12,669.2
+3.49%
APAC Blended Cap
+9.13%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -5.41%  | +3.49%  | +50.77%  | +55.12% | -19.73% | +4.30% | +4.30% | +1.28% | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
Issuer
ISIN
KR7244580007
AuM
€168M
E/R
0.45%
Replication rating
Not rated
ESG Consensus®
More details
NAV
4/20/2026
â‚©12,669.2
1D NAV change
-0.11%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
42
Inception date
5/12/2016
Jurisdiction
South Korea
Distribution
South Korea
Legal structure
Open-end Investment Trust
Base currency
KRW
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
KODEX Biotech ETF invests in stocks of FnGuide Bio Index composed of both KOSPI and KOSDAQ stocks related to biotech industry.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
New to Trackinsight?
For individual investors
Essentials
A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.
More fund data
Compare up to 3 funds
More screener filters
Choose your own screener columns from 100+ metrics
Lists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring
For professional investors
Enterprise
Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.
Request a free trialAdvertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +3.49% | +50.77% | +55.12% | -19.73% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise
Exposure
Countries
Republic of Korea
86.83%
Unavailable
13.17%
Sectors
Health Care
62.34%
Consumer Discretionary
1.97%
Unavailable
35.69%
Diversification
Total weight of top 15 holdings out of 42
Top 15 holdings
Data as of February 28, 2026
SAM CHUN DANG PH
KR7397030008
L&C BIO
VORONOI INC
CHABIOTECH CO LTD
KR7475830006
KR7456160001
HANMI PHARM
Create a free account to view top holdings
CELLTRION
HANMI SCIENCE
KR7445680002
KR70126Z0002
HAN ALL BIOPHARM
CELLTRION PHARM
HUGEL
Create a free account to view top holdings
More risk metrics are available, exclusively in Trackinsight Enterprise
Sustainability
Integrates ESG criteria
No
SDG
More sustainability metrics are available, exclusively in Trackinsight Enterprise
Replication
Trackinsight replication rating:
Not rated
1-year trailing difference
As of March 31, 2026
Create a free account to view the replication graph
244580
N/A
Replication quality
Calculated over 12m, as of March 31, 2026
Tracking error
Tracking difference
1-year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Replication information
Index
Index ticker
Index dividend policy
Replication method
Replication model
Issuer
Samsung Asset Management
Samsung Asset Management ID Card
Number of funds
145
Total AuM
€63.26B
Expense ratio range
0.015% - 2.28%
Average expense ratio
0.3679%
Top 5 funds by Samsung Asset Management
| AuM | ||
|---|---|---|
069500 | Samsung KODEX 200 ETF | €12.32B |
379800 | KODEX S&P500 TR | €4.96B |
459580 | Samsung Kodex CD Rate Active(SYNTH) ETF | €4.68B |
229200 | Samsung KODEX KOSDAQ 150 ETF | €3.85B |
379810 | KODEX US NASDAQ100 TR | €3.84B |
Frequently asked questions about 244580
What does Samsung KODEX Biotech ETF, 244580, invest in?
244580 is a Passive ETF. This ETF provides exposure to Equally Weighted South Korean Biotechnology Equities.
Which benchmark or index does 244580 replicate?
244580 tracks the FnGuide Inc Bio Index - KRW, through a full replication replication method.
What is the Total Expense ratio (TER) of 244580?
244580 carries a total expense ratio (TER) of 0.45%, indicating the annual cost for holding the fund.
When was 244580 launched?
244580 was introduced to the market on May 12, 2016. It trades on South Korea
Who is the ETF issuer of 244580?
Samsung KODEX Biotech ETF, 244580, is provided by Samsung Asset Management. Learn more about Samsung Asset Management here.
What is the current assets under management (AUM) of 244580?
244580 oversees €168M in assets as of April 20, 2026.
How has 244580 performed lately?
Based on data from April 20, 2026, 244580 returned -5.41% over the past month, 3.49% over the last three months and 1.28% year-to-date.
What are the latest inflows or outflows for 244580?
As of April 20, 2026, 244580 recorded net flows of +€2.8M over the last month and +€6.4M year-to-date.
Does 244580 distribute dividends?
244580 follows a distributing dividend policy, meaning it pays out income to investors. As of April 20, 2026, its 12-month trailing yield was 0.12%.
What are the main country or region exposures of 244580?
As of February 28, 2026, 244580 has significant geographic allocations in Republic of Korea.
In which sector or theme does 244580 invest in?
As of February 28, 2026, 244580 focuses largely on Health Care and Consumer Discretionary.
How many securities does 244580 hold and how diversified is it?
As of February 28, 2026, 244580 holds 42 positions in its portfolio, with 39.72% of assets concentrated in its top 15 holdings.
What are the main positions in 244580?
As of February 28, 2026, 244580 top three holdings include SAM CHUN DANG PH, KR7397030008 and L&C BIO.
What is the base currency of 244580?
The base currency of 244580 is KRW.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
